A Study of LY3502970 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Study of LY3305677 in Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
JAK Inhibitor Treatment in AGS
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Different Injectable Formulations of LY3375880 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM
- Status
- TERMINATED
- Phase
- PHASE1
Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- NA
A Study of Injections of LY3074828 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Metastatic Breast Cancer in Austria
- Status
- RECRUITING
- Phase
- N/A
A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3